These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9519148

  • 1. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
    Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ.
    J Pharm Sci; 1998 Feb; 87(2):164-9. PubMed ID: 9519148
    [Abstract] [Full Text] [Related]

  • 2. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
    Chudasama A, Patel V, Nivsarkar M, Vasu K, Shishoo C.
    Drug Deliv; 2015 Feb; 22(4):531-40. PubMed ID: 24601856
    [Abstract] [Full Text] [Related]

  • 3. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats.
    Zhou A, Lu T, Wang L, Lu C, Wang L, Wan M, Wu H.
    Pharm Dev Technol; 2014 Sep; 19(6):743-7. PubMed ID: 23978005
    [Abstract] [Full Text] [Related]

  • 4. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
    Lind ML, Jacobsen J, Holm R, Müllertz A.
    Eur J Pharm Sci; 2008 Oct 02; 35(3):211-8. PubMed ID: 18675904
    [Abstract] [Full Text] [Related]

  • 5. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues.
    Caliph SM, Faassen WA, Vogel GM, Porter CJ.
    Curr Drug Deliv; 2009 Aug 02; 6(4):359-66. PubMed ID: 19534711
    [Abstract] [Full Text] [Related]

  • 6. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H, Zhou A, Lu C, Wang L.
    Eur J Pharm Sci; 2011 Mar 18; 42(4):348-53. PubMed ID: 21216284
    [Abstract] [Full Text] [Related]

  • 7. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs.
    Iwanaga K, Kushibiki T, Miyazaki M, Kakemi M.
    Biol Pharm Bull; 2006 Mar 18; 29(3):508-12. PubMed ID: 16508155
    [Abstract] [Full Text] [Related]

  • 8. The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623).
    Trevaskis NL, McEvoy CL, McIntosh MP, Edwards GA, Shanker RM, Charman WN, Porter CJ.
    Pharm Res; 2010 May 18; 27(5):878-93. PubMed ID: 20221896
    [Abstract] [Full Text] [Related]

  • 9. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL, Nguyen G, Charman WN, Edwards GA, Faassen WA, Porter CJ.
    J Pharmacol Exp Ther; 2009 Nov 18; 331(2):700-9. PubMed ID: 19696095
    [Abstract] [Full Text] [Related]

  • 10. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
    Griffin BT, O'Driscoll CM.
    J Pharm Pharmacol; 2006 Jul 18; 58(7):917-25. PubMed ID: 16805951
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats.
    Sun M, Zhai X, Xue K, Hu L, Yang X, Li G, Si L.
    Eur J Pharm Sci; 2011 Jun 14; 43(3):132-40. PubMed ID: 21530655
    [Abstract] [Full Text] [Related]

  • 14. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF, Yao TT, Zhang XX, Gan L, Zhu C, Yu HZ, Gan Y.
    Int J Pharm; 2009 Sep 08; 379(1):18-24. PubMed ID: 19508887
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y, Kostewicz ES, Sheu MT, Dressman JB.
    Eur J Pharm Biopharm; 2013 Nov 08; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [Abstract] [Full Text] [Related]

  • 18. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.
    Porter CJ, Charman SA, Charman WN.
    J Pharm Sci; 1996 Apr 08; 85(4):351-6. PubMed ID: 8901067
    [Abstract] [Full Text] [Related]

  • 19. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG.
    Int J Pharm; 2009 Jun 05; 374(1-2):66-72. PubMed ID: 19446761
    [Abstract] [Full Text] [Related]

  • 20. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU, Nguyen TH, Yeap YY, Feeney OM, Williams HD, Benameur H, Pouton CW, Porter CJ.
    Mol Pharm; 2014 Nov 03; 11(11):4069-83. PubMed ID: 25265395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.